Clinical Trials Browser

Phase 1 × Genz-644282 × Clear all

NCT00942799 2014-03-19

Dose Escalation Study to Assess the Safety and Tolerability of Genz-644282 in Patients With Solid Tumors

Phase 1 Completed

Metatropic dwarfism, Neoplasms